| |
NewswireToday - /newswire/ -
New York, NY, United States, 08/01/2007 - Twenty five companies experienced CEO changes during July for which investors might wish to re-examine for investment possibilities. Liberum's Management Change Database registered an overall total of 169 CEO related changes during that period.
|
| |
CEO CHANGES
As has been the case for the last number of months, we have found a significant number of companies (25) that experienced CEO changes during July for which investors might wish to re-examine for investment possibilities. According to Liberum's Management Change Database, 169 CEO related changes occurred during July 2007. Below is a list of specific companies that underwent CEO changes Liberum has highlighted that investors might wish to re-examine for investment potential either positive or negative.
25 COMPANIES WITH CEO CHANGES WORTH RE-EXAMINING
Here are 25 from July 2007 that caught my eye. I'm looking for situations where I think a particularly strong or particularly weak choice has been made - given the apparent current state of the company - or where there is an interesting special situation.
7/2 Blockbuster BBI (NYSE) $856 million (check the Liberum blog)
7/2 Community Bancorp CBON (NASDAQ) $286 million
7/2 InPlay Technologies, Inc. NPLA (NASDAQ) $28 million
7/3 Allied Healthcare International Inc. AHCI`(NASDAQ)
7/3 Interleukin Genetics ILI (AMEX) $49 million
7/5 Pomeroy IT Solutions PMRY (NASDAQ) $126 million
7/5 UBS AG USA UBS (NYSE) $118.5 billion (check the Liberum blog)
7/11 Aspreva Pharmaceuticals ASPV (NASDAQ) $687 million (check the Liberum blog)
7/11 Bookham BKHM (NASDAQ) $208 million
7/12 Cytocore Inc. CYCR (OTC BB) $123 million
7/12 Hypercom Corporation HYC (NYSE) $327 million
7/16 Atlas Mining Corp. ALMI (OTC BB) $152 million
7/16 Avid Technology Inc. AVID (NASDAQ) $1.559 billion
7/16 Spartech Corporation SEH (NYSE) $705 million (check the Liberum Blog)
7/18 Assurant Inc. AIZ (NYSE) $6.713 billion
7/18 Scottish Re Group Limited SCT (NYSE) $324 million
7/19 Exactech, Inc. EXAC (NASDAQ) $185 million
7/19 SM&A WINS (NYSE) $135 million (check the Liberum blog)
7/24 Blue Holdings Inc. BLUE (NASDAQ) $36 million
7/24 Maxwell Technologies, Inc. MXWL (NYSE) $249 million
7/24 Princeton Review, Inc. REVU (NYSE) $145 million (check the Liberum blog)
7/25 Novadel Pharma, Inc. NVD (NASDAQ) $44 million
7/26 Johnson Controls JCI (NYSE) $22.226 billion
7/26 The Gap Inc. GPS (NYSE) $13.797 billion (check the Liberum blog)
7/27 Kreido Biofuels I KRBF (OTC BB) $39 million
Investors need to diligently monitor key management changes. Certain management changes should be viewed as a "special situation" that can have a direct and major impact on a company's performance and share price.
New CEOs know more than the market about the company. Their decision contains information. Likewise the departing CEO. Likewise departing CFOs.
New CEOs will bring new skills and a new direction. This is normally significant, and worth analyzing.
The next step is to get a reliable source of these investment leads - and that's why funds use Liberum (a division of The Wall Street Transcript)
Liberum expects the overall level of management change to continue to remain high, yet show signs of moderation as we move through the the slower summer months, particularly at the top levels of corporate management. Outlined below is a breakdown of the key management change totals for July 2007. Two key categories (CEO & CFO) totals for July are slightly lower overall than was registered for the same categories in 2006. Overall management turnover, however, increased a mere 1%, while CEO turnover declined 3%, and CFO turnover declined 6%. Overall the turnover trend has slowed appreciably from that registered over the last few months. The slowdown coincides with the same slowdown experienced in the summer months of 2006 and 2005. For detailed information behind the statistics or for comparison annual and/or geographic data contact Liberum Research directly.
JULY 2007 MANAGEMENT CHANGE STATISTICS C-LEVEL MANAGEMENT CHANGE STATISTICS - GRAND TOTAL - 1,986
TOP INDUSTRY SECTORS
Banking - 204
Drugs/Biotech - 176
Metals/Mining - 128
TOP INDUSTRY SECTORS FOR NEW HIRES ONLY GRAND TOTAL - 1,002 or 50% of grand total
Banking - 122
Drugs/Biotech - 86
Energy - 70
JULY 2007 C-LEVEL TOTAL BREAKDOWNS BY STATUS
15% or 291 were internal moves
50% or 1,002 were new hires from outside the firm
0% or 4 left firms without clear explanation
23% or 447 were promoted within the firm
12% or 237 resigned or retired from the firm
0% or 5 were terminated
JULY 2007 CEO CHANGE STATISTICS GRAND TOTAL - 169 TOP INDUSTRY SECTORS
Banking - 19
Drugs/Biotech - 17
Energy - 12
Manufacturing - 12
TOP INDUSTRY OUTSIDE CEO HIRES ONLY TOTAL - 33 OR 20% OF GRAND TOTAL
Metals/Mining - 4
Banking - 3
Business Services - 3
Drugs/Biotech - 3
Insurance - 3
Manufacturing - 3
JULY 2007 CEO LEVEL BREAKDOWNS BY STATUS
34% or 57 were internal moves
20% or 33 were new hires from outside the firm
0% or 0 left firms without clear explanation
24% or 40 were promoted within the firm
22% or 38 resigned or retired from the firm
1% or 1 was terminated
JULY 2007 CFO CHANGE STATISTICS GRAND TOTAL - 166 TOP INDUSTRY SECTORS
Metals/Mining - 20
Drugs/Biotech - 17
Banking - 14
TOP INDUSTRY OUTSIDE CFO HIRES ONLY TOTAL - 62 OR 37% OF GRAND TOTAL
Metals/Mining - 9
Drugs/Biotech - 6
Consumer Products - 6
JULY 2007 BOARD OF DIRECTOR CHANGE STATISTICS GRAND TOTAL - 471 TOP INDUSTRY SECTORS
Real Estate - 59
Energy - 39
Drugs/Biotech - 38
TOP INDUSTRY OUTSIDE DIRECTOR HIRES ONLY TOTAL - 304 OR 65% OF GRAND TOTAL
Real Estate - 49
Energy - 27
Banking - 24
About Liberum
The largest database of C-level executive change at public companies. Frequently quoted in the financial press, Liberum helps investors monitor this important, continuous stream of investment events. The data is also useful for investment bankers, private equity, executive search and consulting firms.
Daily customizable alerts, a searchable database, custom reports, xml feeds. Liberum clients get the data the way they can best exploit it. Get a short trial. And check out our new management change blog.
|